Endocrinology in catabolic illness

Endocrinology and Metabolism, Supplement

Volumn 3, Issue SUPPL. A, 1996, Pages 115-118

  Ross, Richard J M ^a,b   Wilmore, Douglas W ^a,b  

^a NORTHERN GENERAL HOSPITAL   (United Kingdom)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANABOLIC AGENT; GROWTH HORMONE; NITROGEN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BODY COMPOSITION; BURN; CATABOLISM; CLINICAL TRIAL; CONFERENCE PAPER; CRITICAL ILLNESS; ENDOCRINOLOGY; GROWTH HORMONE RELEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALABSORPTION; NITROGEN BALANCE; PARENTERAL NUTRITION; PRIORITY JOURNAL; QUALITY OF LIFE; SHORT BOWEL SYNDROME; SUBCUTANEOUS DRUG ADMINISTRATION; WEIGHT REDUCTION;

EID: 0029493641     PISSN: 1074939X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Ross RJM, Miell J, Freeman E, Jones J, Matthews D, Preece M, Buchanan C. Critically ill patients have high basal growth hormone levels with attenuated oscillatory activity associated with low levels of insulin like growth factor-l. Clin. Endocrinol. 1991; 35: 47-54.
2. Voerman HJ, Strack Van Schijndel RJM, Groeneveld ABJ, De Boer H, Nauta JP, Thijs LG. Pulsatile hormone secretion during severe sepsis: accuracy of different blood sampling regimens. Metabolism 1992; 9: 934-940.
3. Van Den Berghe G, De Zegher F, Lauwers P, Veldhuis JD. Growth hormone secretion in critical illness: effect of dopamine. J. Clin. Endocrinol. Metab. 1994; 79: 1141-1146.
4. Iranmanesh A, Lizarralde G, Veldhuis JD. Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men. J. Clin. Endocrinol. Metab. 1991; 73: 1081-1088.
5. Melarvie S, Jeevanadam M, Holaday NJ, Petersen SR. Pulsatile nature of growth hormone levels in critically ill trauma victims. Surgery 1995; 117: 402-408.
6. Asplin CM, Faria ACS, Carlsen EC, Vaccaro VA, Barr RE, Iranmanesh A, Lee MM, Veldhuis JD, Evans WS. Alterations in the pulsatile mode of growth hormone release in men and, women with insulin-dependent diabetes mellitus. J. Clin. Endocrinol. Metab. 1989; 69: 239-245.
7. Cuneo RC, Hickman PE, Wallace JD, Teh BT, Ward G, Veldhuis JD, Waters MJ. Altered endogenous growth hormone secretory kinetics and diurnal GH-binding protein profiles in adults with chronic liver disease. Clin. Endocrinol. 1995; 32: 265-275.
8. Nygren J, Sammann M, Malm M, Efendic S, Hall K, Brismar K, Ljungqvist O. Disturbed anabolic hormonal patterns in burned patients: the relation to glucagon. Clin. Endocrinol. 1995; 43: 491-500.
9. Ho KY, Veldhuis JD, Johnson ML, Furlanetto R, Evans WS, Alberti KGMM, Thorner MO. Fasting enhances growth hormone secretion and amplifies the complex rhythms of growth hormone secretion in man. J. Clin. Endocrinol. Metab. 1988; 81: 968-975.
10. Jones JL, Clemmons DR. Insulin-like growth factors and their binding proteins: biological actions. Endocrine Rev. 1995; 16: 3-34.
11. Frayn KN, Price DA, Maycock PF, Carroll SM. Plasma somatomedin activity after injury in man and its relationship to other hormonal and metabolic changes. Clin. Endocrinol. 1984; 20: 179-187.
12. Phillips LS, Unterman TG. Somatomedin activity in disorders of nutrition and metabolism. J. Clin. Endocrinol. Metab. 1995; 13: 145-189.
13. Ross RJM, Miell JP, Holly JMP, Maheshwari H, Norman M, Abdulla AF, Buchanan CR. Levels of GH and IGF binding proteins, insulin, blood glucose and Cortisol in intensive care patients. Clin. Endocrinol. 1991; 35:361-367.
14. Holly JMP, Claffey DCP, Cwyfan-Hughes SC, Frost VJ, Yateman ME. Proteases acting on IGFBPs; their occurrence and physiological significance. Growth Reg. 1993; 3: 88-91.
15. Miell JP, Taylor AM, Jones J, Buchanan CR, Rennie J, Sherwood R, Leicester R, Ross RJM. Administration of human recombinant insulin-like growth factor-l to patients following major gastrointestinal surgery. Clin. Endocrinol. 1992; 37: 542-551.
16. Lemmey AB, Martin AA, Read LC, Tomas FM, Owens PC, Ballard FJ. IGF-I and the truncated analogue des-(1,3) IGF-I enhance growth in rats after gut resection. Am. J. Physiol. 1991; 260: 213-219.
17. Shernan SK, Demling RH, Lalonde C, Löwe DK, Eriksson E, Wilmore DW. Growth hormone enhances re-epithelialisation of human split-thickness skin graft donor site. Surg. Forum 1989; 40: 37-39.
18. Herndon DN, Barrow RE, Kunkel KR. Effect of recombinant human growth hormone on donor-site healing in severely burned children. Ann. Surg. 1990; 212: 424-429.
19. Knox J, Demling R, Wilmore DW, Sarraf P, Santos A. Increased survival after major thermal injury: the effect of growth hormone therapy in adults. J. Trauma 1995; 39: 526-530.
20. Byrne TA, Morrissey TB, Nattakom TV, Ziegler TR, Wilmore DW. Growth hormone, glutamine and a modified diet enhance nutrient absorption in patients with severe short bowel syndrome. JPEN 1995; 19: 296-302.
21. Byrne TA, Persinger RL, Young LS, Ziegler TR, Wilmore DW. A new treatment for patients with short bowel syndrome. Ann. Surg. 1995; 222: 243-255.
22. Hoover DR, Saah AJ, Bacellar H, Phair J, Detels R, Anderson R, Kaslow RA. Clinical manifestations of AIDS in the era of pneumocystis prophylaxis. N. Engl. J. Med. 1993; 329: 1922-1926.
23. Weiss PJ, Wallace MR, Olsen PE, Rossetti R. Change in the mix of AIDS-defining conditions. N. Engl. J. Med. 1993; 329: 1962.
24. Suttmann U, Ockenga J, Seiberg O, Hoogestraat L, Deicher H, Muller MJ. Incidence and prognostic value of malnutrition and wasting in human immunodeficiency virus-infected patients. J. AIDS 1995; 8: 239-246.
25. Ott M, Fischer H, Polat H, Helm EB, Frenz M, Caspary WF, Lemboke B. Bioelectrical impedance analysis as a predictor of survival in patients with human immunodeficiency virus infection. J. AIDS 1995; 9: 20-25.
26. Kotler DP, Tierney AR, Wang J, Pierson RN Jr. Magnitude of body-cell-mass depletion and the timing of death from wasting in AIDS. Am. J. Clin. Nutr. 1989; 50: 444-447.
27. Kotler DP, Tierney AR, Culpepper-Morgan JA, Wang J, Pierson RN Jr. Effect of home total parenteral nutrition on body composition in patients with acquired immunodeficiency syndrome. JPEN 1990; 14: 454-458.
28. Von Roenn JH, Armstrong D, Kotler DP, Cohn DL, Klimas NG, Tchekmedyian NS, Cone L, Brennan PJ, Weitzman SA. Megestrol acetate in patients with AIDS-related cachexia. Ann. Intern. Med. 1994; 121: 393-399.
29. Oster MH, Enders SR, Samuels SJ, Cone LA, Hooton TM, Browder HP, Flynn NM. Megestrol acetate in patients with AIDS and cachexia. Ann. Intern. Med. 1994; 121:400-408.
30. Mulligan K, Grunfeld C, Hellerstein MK, Neese RA, Schambelan M. Anabolic effects of recombinant human growth hormone in patients with wasting associated with human immunodeficiency virus infection. J. Clin. Endocrinol. Metab. 1993; 77: 956-962.
31. Schambelan M, Mulligan K, Grunfeld C, Daar E, Lamarca A Brietmeyer J. Recombinant human growth hormone (rhGH) increases lean body mass (LBM) and improves functional performance in patients with HIV-associated wasting. 2nd Conference on Retroviruses and Opportunistic Infections 1995 (Abstract).